There are few studies on the role of NCCRP1, RNF25, and UBE2H in cancer, but the existing research results suggest that these three genes also have the potential to become new tumor biomarkers or targets for cancer (Miwa et al., 2017; Cho et al., 2018; Zhu et al., 2018). This evidence concerns the gene UBE2H and neoplasm.